Recombinant Human ER alpha protein (His tag)
SKU: PDEH100237-100
To better serve you, we would like to discuss your specific requirement.
Please Contact Us for a quote.
Recombinant Human ER alpha protein (His tag)
SKU # | PDEH100237 |
Expression Host | E. coli |
Description
Synonyms | Estrogen Receptor α;Estrogen Receptor;ER;ER-Alpha;Estradiol Receptor;Nuclear Receptor Subfamily 3 Group A Member 1;ESR1;ESR;NR3A1 |
Species | Human |
Expression_host | E.coli |
Sequence | Met 297-Ser 554 |
Accession | P03372 |
Mol_Mass | 28.3 kDa |
AP_Mol_Mass | 31 kDa |
Tag | N-His |
Bio_Activity | Not validated for activity |
Properties
Purity | > 95 % as determined by reducing SDS-PAGE. |
Endotoxin level | Please contact us for more information. |
Storage | Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months. |
Shipping | This product is provided as lyophilized powder which is shipped with ice packs. |
Formulation | Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
Reconstitution | It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis |
Background
Estrogen Receptor is a major ligand-activated transcription factor belonging to the nuclear hormone receptor superfamily. Estrogen Receptor is composed of several domains important for hormone binding, DNA binding, and activation of transcription. The protein localizes to the nucleus where it may form a homodimer or a heterodimer with estrogen receptor 2. Estrogen and its receptors are essential for sexual development and reproductive function, but they also play a role in other tissues such as bone. Estrogen receptors are also involved in pathological processes including breast cancer, endometrial cancer, and osteoporosis. Alternative splicing results in several transcript variants, which differ in their 5' UTRs and use different promoters.